vendredi 27 juin 2014

New test predicts risk of non-hereditary breast cancer

A simple blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, even in the absence of a high-risk BRCA1 gene mutation, according to research. Researchers identified an epigenetic signature in the blood of women predisposed for breast cancer. Strikingly, the same signature was discovered in the blood of women without a BRCA1 mutation but who went on to develop breast cancer, making it a potential early marker of women's cancer in the general population.

New test predicts risk of non-hereditary breast cancer

Aucun commentaire:

Enregistrer un commentaire